Complete report $7,900. DataPack (test volumes, sales forecasts, supplier shares) $5,100.
This new 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, and Syphilis. The report provides test volume and sales forecasts by country and market segment, including:
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country. Also, the report:
- Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used
for STD testing;
- Profiles key suppliers and potential market entrants developing innovative
technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in major European countries.
In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Groups proprietary data files was conducted.
Contains 318 pages and 58 tables
SIMILAR MARKET STUDIES
This new report from VPGMarketResearch.com provides analyses of 100 major and emerging suppliers of immunodiagnostics, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents. The report presents strategic profiles of 100 major and emerging suppliers of diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
October 2015 | $0 | View Details >>
This DataPack presents Japanese test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs - Blood Banks The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Fujirebio, Grifols, Ortho Clinical Diagnostics/J&J, Roche, and Siemens.List of Tables
July 2015 | $0 | View Details >>
2015 Analysis of Emerging Cancer Diagnostic Tests, and Strategic Profile of Leading Suppliers This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
January 2015 | $0 | View Details >>
Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2015-2019 Future Horizons and Growth Strategies in the Global Microbiology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in the ...
September 2015 | $21100 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research